|To the Editor: Cancer funding comment clarified||| Print ||
|Written by Dr. Louann Cummings|
|Wednesday, 05 August 2009 09:01|
My heartfelt thanks to Karen Cota for the fine article she wrote about my lung cancer journey and recent advocacy and fundraising endeavors. However, I must clarify a quote I made which could be misinterpreted and for which I am sorry.
While referring to lung cancer research funding, I tried to make the point that researchers, advertisers, and advocates are most interested in and attracted to the cancers where research dollars are available and tangible results are evident. Even though lung cancer causes one in every three cancer deaths, it remains the most underfunded and stigmatized of cancers. The bottom line is research spending per death for breast, prostate, and colon cancer is many multiples that spent on lung cancer research. Additionally, those cancers' five year survival rates range between 64-99% while lung cancer's has remained flat at approximately 15% for decades (http://www.lungcanceralliance.org/facing/facts.html). Until research monies are deployed to lung cancer diagnostics and treatment, it will prevail as a major societal foe.
Dr. Louann Cummings